Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial
Miyai I, Fujimoto Y, Yamamoto H, Ueda Y, Saito T, Nozaki S, Kang J
Archives of Physical Medicine and Rehabilitation 2002 Oct;83(10):1370-1373
clinical trial
4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: To investigate whether body weight-supported treadmill training (BWSTT) is of long-term benefit for patients with Parkinson's disease (PD). DESIGN: Randomized controlled trial. SETTING: Inpatient rehabilitation unit for neurologic diseases in Japan. PARTICIPANTS: Twenty-four patients (Hoehn and Yahr stages 2.5 or 3) who were not demented (Mini-Mental State Examination score, > 27). INTERVENTIONS: Patients were randomized to receive either a 45-minute session of BWSTT (up to 20% of body weight supported) or conventional physical therapy (PT) for 3 days a week for 1 month. MAIN OUTCOME MEASURES: Outcome measures were evaluated at baseline and at 1, 2, 3, and 6 months. Measures included the Unified Parkinson's Disease Rating Scale (UPDRS), ambulation speed (s/10 m), and number of steps taken for a 10-m walk as a parameter for stride length. RESULTS: Four patients needed modification of medications in the follow-up period. Twenty patients (BWSTT, n = 11; PT, n = 9) without modified medications were analyzed for functional outcome. Age, duration of PD, gender, and doses of medications were comparable. There was no difference in the baseline UPDRS (BWSTT 33.3; PT 32.6), speed (BWSTT 10.8; PT 11.5), and steps (BWSTT 23.4; PT 22.8). The BWSTT group had significantly greater improvement than the PT group (Mann-Whitney U test, Bonferroni adjustment for multiple comparison) in ambulation speed at 1 month (BWSTT 8.5; PT 10.8; p < 0.005); and in the number of steps at 1 (BWSTT 20.0; PT 22.7; p < 0.005), 2 (BWSTT 19.5; PT 22.4; p < 0.005), 3 (BWSTT 20.1; PT 23.1; p < 0.005), and 4 months (BWSTT 21.0; PT 23.0; p = 0.006). CONCLUSIONS: BWSTT has a lasting effect specifically on short-step gait in PD.

Full text (sometimes free) may be available at these link(s):      help